Cargando…

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation

BACKGROUND: As a novel immune checkpoint molecular, T-cell immunoglobulin mucin 3 (TIM-3) is emerging as a therapeutic target for cancer immunotherapy. However, the predictive role of TIM-3 in cancer remains largely undetermined. This study was designed to investigate the role of TIM-3 in cancer. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Kui, Hui, Liangliang, Wang, Min, Huang, Ying, Zhu, Xingxing, Yao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938756/ https://www.ncbi.nlm.nih.gov/pubmed/33692946 http://dx.doi.org/10.3389/fonc.2021.579351

Ejemplares similares

The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020)

Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
por: Qin, Shuang, et al.
Publicado: (2020)

Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis
por: Hu, Yanyan, et al.
Publicado: (2022)

Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation
por: Zhou, Liuqing, et al.
Publicado: (2022)

Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021)

The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023)

The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis
por: Roufas, Constantinos, et al.
Publicado: (2018)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis
por: Gan, Kai, et al.
Publicado: (2021)

Tim3 and PD-1 as a therapeutic and prognostic targets in colorectal cancer: Relationship with sidedness, clinicopathological parameters, and survival
por: Mokhtari, Zahra, et al.
Publicado: (2023)

TIM-3 in Leukemia; Immune Response and Beyond
por: Rezaei, Mahnaz, et al.
Publicado: (2021)

Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis
por: Jin, Yao, et al.
Publicado: (2021)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Validating HMMR Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods
por: Li, Xia, et al.
Publicado: (2021)

New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation
por: Zhou, Sitong, et al.
Publicado: (2021)

Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods
por: Wei, Chao, et al.
Publicado: (2022)

Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis
por: Li, Hui, et al.
Publicado: (2021)

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022)

TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis
por: Zhang, Yang, et al.
Publicado: (2017)

FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta−Analysis and Bioinformatics Analysis
por: Zhang, Guangming, et al.
Publicado: (2022)

Prognostic significance of CDC20 expression in malignancy patients: A meta-analysis
por: Xian, Feng, et al.
Publicado: (2022)

Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis
por: Yao, Zhen, et al.
Publicado: (2020)

Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer
por: Yu, Wei, et al.
Publicado: (2022)

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021)

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
por: Wu, Xin, et al.
Publicado: (2023)

TIM-3, a promising target for cancer immunotherapy
por: He, Yayi, et al.
Publicado: (2018)

The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: A meta-analysis
por: Li, Baibei, et al.
Publicado: (2022)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review
por: Martin, Enrico, et al.
Publicado: (2020)

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling
por: Zhang, Yang, et al.
Publicado: (2022)

Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
por: Qiao, Shaoyi, et al.
Publicado: (2022)

Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
por: Ukleja, Jacob, et al.
Publicado: (2021)

Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis
por: Wang, Chengcheng, et al.
Publicado: (2022)

Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study
por: Zhang, Lan, et al.
Publicado: (2023)

Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer
por: Li, Wan-Wan, et al.
Publicado: (2022)

Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis
por: Li, Yalun, et al.
Publicado: (2020)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
por: Jin, Shenhe, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer
por: Kong, Xiaoxiao, et al.
Publicado: (2020)

N-Glycosylation at Asn291 Stabilizes TIM-4 and Promotes the Metastasis of NSCLC
por: Chen, Siyuan, et al.
Publicado: (2022)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mtb9pkb7hpc4sfk7da217bhnaf